Publication | Closed Access

Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia

Hematological MalignancyOncologyPharmacokinetic ModelingGemtuzumab OzogamicinMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaHematologyPharmacologyPopulation Pharmacokinetic ModelingPharmacotherapyMedicinePharmacodynamic ModelingMyeloid Neoplasia